Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Clinical Insights

Clinical Insights
Results From the Coiling vs Surefire Infusion System in Y90 Trial: An Interview With Aaron Fischman, MD
05/15/2014
In March, data from the Coiling vs Surefire Infusion System in Y90 (COSY) clinical trial were presented at the Society for Interventional Radiology meeting in San Diego.  Results showed significant reductions in the endpoints of...
In March, data from the Coiling vs Surefire Infusion System in Y90 (COSY) clinical trial were presented at the Society for Interventional Radiology meeting in San Diego.  Results showed significant reductions in the endpoints of...
In March, data from the Coiling...
05/15/2014
IO Learning
Clinical Insights
Transarterial Chemoembolization in Neuroendocrine Liver Metastasis
05/14/2014
Abstract: Neuroendocrine tumors (NET) are rare neoplasms that present in up to 40% of patients with metastasis at diagnosis, notably in the liver. Radical surgery is the treatment of choice, however it is seldom possible  in patients...
Abstract: Neuroendocrine tumors (NET) are rare neoplasms that present in up to 40% of patients with metastasis at diagnosis, notably in the liver. Radical surgery is the treatment of choice, however it is seldom possible  in patients...
Abstract: Neuroendocrine tumors...
05/14/2014
IO Learning
Clinical Insights
The Global Embolization Symposium and Technologies (GEST) Meeting: An Interview With Jafar Golzarian, MD
04/16/2014
Jafar Golzarian, MD, is professor of radiology at the University of Minnesota Department of Diagnostic Radiology. Dr. Golzarian reports no related disclosures.The Global Embolization Symposium and Technologies (GEST) aims to provide attendees...
Jafar Golzarian, MD, is professor of radiology at the University of Minnesota Department of Diagnostic Radiology. Dr. Golzarian reports no related disclosures.The Global Embolization Symposium and Technologies (GEST) aims to provide attendees...
Jafar Golzarian, MD, is...
04/16/2014
IO Learning
Clinical Insights
Interventional Oncology at Vanderbilt University: An Interview With Daniel Brown, MD
04/03/2014
At the 2014 Symposium on Clinical Interventional Oncology (CIO), faculty member Daniel Brown, MD, chief of interventional oncology, a new division within the department of radiology and radiological sciences at Vanderbilt University,...
At the 2014 Symposium on Clinical Interventional Oncology (CIO), faculty member Daniel Brown, MD, chief of interventional oncology, a new division within the department of radiology and radiological sciences at Vanderbilt University,...
At the 2014 Symposium on...
04/03/2014
IO Learning
Clinical Insights
The Metastatic Colorectal Cancer Liver Metastases Outcomes After Radio Embolization (MORE) Study Results: An Interview With Andrew S. Kennedy, MD, FACRO
03/13/2014
Researchers involved in the MORE (Metastatic colorectal cancer liver metastases Outcomes after Radio Embolization) study released new findings at the American Society of Clinical Oncology’s 2014 Gastrointestinal Cancers Symposium (ASCOGI)...
Researchers involved in the MORE (Metastatic colorectal cancer liver metastases Outcomes after Radio Embolization) study released new findings at the American Society of Clinical Oncology’s 2014 Gastrointestinal Cancers Symposium (ASCOGI)...
Researchers involved in the MORE...
03/13/2014
IO Learning
Clinical Insights
Irreversible Electroporation at Sylvester Comprehensive Cancer Center: An Interview With Govindarajan Narayanan, MD
02/27/2014
IO360 sat down with clinical editor Govindarajan Narayanan, MD, of the University of Miami Miller School of Medicine Sylvester Comprehensive Cancer Center (SCCC) to discuss the use of irreversible electroporation (IRE) at SCCC.Q: Please...
IO360 sat down with clinical editor Govindarajan Narayanan, MD, of the University of Miami Miller School of Medicine Sylvester Comprehensive Cancer Center (SCCC) to discuss the use of irreversible electroporation (IRE) at SCCC.Q: Please...
IO360 sat down with clinical...
02/27/2014
IO Learning
Clinical Insights
Transarterial Chemoembolization for Unresectable Hepatocelluar Carcinoma
01/23/2014
Abstract: Transarterial chemoembolization has been shown to effectively downsize unresectable hepatocellular carcinoma, thereby “bridging” patients to liver transplant. We present a case of a 66-year-old male with cirrhosis and two...
Abstract: Transarterial chemoembolization has been shown to effectively downsize unresectable hepatocellular carcinoma, thereby “bridging” patients to liver transplant. We present a case of a 66-year-old male with cirrhosis and two...
Abstract: Transarterial...
01/23/2014
IO Learning
Clinical Insights
Treatment Options for Thrombocytopenia in Cancer Patients
12/19/2013
Abstract: Thrombocytopenia can limit administration of chemotherapy, which can adversely affect cancer patient outcomes. Management options ranging from innovations in medical management to invasive options are reviewed in this paper. While...
Abstract: Thrombocytopenia can limit administration of chemotherapy, which can adversely affect cancer patient outcomes. Management options ranging from innovations in medical management to invasive options are reviewed in this paper. While...
Abstract: Thrombocytopenia can...
12/19/2013
IO Learning
Clinical Insights
The 6th Annual Symposium on Clinical Interventional Oncology
12/18/2013
Six years ago, at the conclusion of the International Symposium on Endovascular Therapy meeting, Shaun Samuels, MD, met with his colleagues from the Baptist Cardiac & Vascular Institute in Miami, Florida, to discuss offering a symposium that...
Six years ago, at the conclusion of the International Symposium on Endovascular Therapy meeting, Shaun Samuels, MD, met with his colleagues from the Baptist Cardiac & Vascular Institute in Miami, Florida, to discuss offering a symposium that...
Six years ago, at the conclusion...
12/18/2013
IO Learning
Clinical Insights
Combined Interventional Therapy With Imaging-Guided Drainage, Embolization, and Sclerotherapy of a Recurrent Sacral Chordoma
11/19/2013
AbstractWe present the case of a 71-year-old female with recurrence of a large sacral chordoma and associated local spread. Symptoms consisted of bladder-bowel difficulties, pelvic pressure, and pelvic pain. Past therapies included partial...
AbstractWe present the case of a 71-year-old female with recurrence of a large sacral chordoma and associated local spread. Symptoms consisted of bladder-bowel difficulties, pelvic pressure, and pelvic pain. Past therapies included partial...
AbstractWe present the case of a...
11/19/2013
IO Learning

Advertisement

Subscribe

IO Learning Newsletter

News

News
Novel Endovascular Robotic Surgical System Reaches Midpoint of Pivotal Clinical Trial
09/20/2024
The ACCESS-PVI trial of LIBERTY® Endovascular Robotic Surgical System has enrolled and completed follow-up for 50% of patients.
The ACCESS-PVI trial of LIBERTY® Endovascular Robotic Surgical System has enrolled and completed follow-up for 50% of patients.
The ACCESS-PVI trial of LIBERTY®...
09/20/2024
IO Learning
News
Histotripsy Demonstrates Technical Success, Safety for Primary and Metastatic Liver Tumors
09/04/2024
According to results from the parallel #HOPE4LIVER trials, the novel ablation technique of histotripsy met coprimary end points for technical success and safety among patients with primary and metastatic liver tumors.
According to results from the parallel #HOPE4LIVER trials, the novel ablation technique of histotripsy met coprimary end points for technical success and safety among patients with primary and metastatic liver tumors.
According to results from the...
09/04/2024
IO Learning
News
Sorafenib Plus Transarterial Chemoembolization Improves Survival Outcomes, Response Among Patients With Recurrent Hepatocellular Carcinoma
07/29/2024
According to a phase 3 trial, the addition of sorafenib to TACE improved survival outcomes and response among patients with recurrent intermediate-stage hepatocellular carcinoma after R0 initial hepatectomy and microvascular invasion.
According to a phase 3 trial, the addition of sorafenib to TACE improved survival outcomes and response among patients with recurrent intermediate-stage hepatocellular carcinoma after R0 initial hepatectomy and microvascular invasion.
According to a phase 3 trial,...
07/29/2024
Oncology
News
Thermal Ablation Over Surgical Resection for Patients With Smaller Colorectal Liver Metastases
07/18/2024
According to the phase 3 COLLISION trial, thermal ablation for smaller colorectal liver metastases reduced morbidity and mortality without compromising survival outcomes compared to surgical resection.
According to the phase 3 COLLISION trial, thermal ablation for smaller colorectal liver metastases reduced morbidity and mortality without compromising survival outcomes compared to surgical resection.
According to the phase 3...
07/18/2024
IO Learning
News
Manageable Safety Across Treatment Periods for Durvalumab, Bevacizumab, and TACE Regimen Among Patients With Unresectable Hepatocellular Carcinoma
07/17/2024
According to a post-hoc, exploratory analysis of safety by treatment period in the EMERALD-1 study, durvalumab plus bevacizumab plus transarterial chemoembolization had a manageable safety profile across both treatment periods among patients...
According to a post-hoc, exploratory analysis of safety by treatment period in the EMERALD-1 study, durvalumab plus bevacizumab plus transarterial chemoembolization had a manageable safety profile across both treatment periods among patients...
According to a post-hoc,...
07/17/2024
IO Learning
News
Transit Scientific Announces First Worldwide Case Performed with Innovative Embolic-Delivery Microcatheter
07/09/2024
Transit Scientific Press Release Park City, Utah USA, July 9, 2024 – Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, proudly announces the successful debut of XO...
Transit Scientific Press Release Park City, Utah USA, July 9, 2024 – Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, proudly announces the successful debut of XO...
Transit Scientific Press...
07/09/2024
Vascular Disease Management
Imaging Systems
University Hospitals Cleveland, Siemens Healthineers in New Alliance to Improve Oncology, Cardiovascular and Neurovascular Care for Patients
05/08/2024

Siemens Healthineers and University Hospitals Cleveland News

Siemens Healthineers and University H...
The new alliance will enhance cardiovascular services of the UH Harrington Heart & Vascular Institute with the world’s first clinically available photon-counting CT scanner and the new dual-source CT scanner.
The new alliance will enhance cardiovascular services of the UH Harrington Heart & Vascular Institute with the world’s first clinically available photon-counting CT scanner and the new dual-source CT scanner.
The new alliance will enhance...
05/08/2024
Cath Lab Digest
News
Histotripsy Treatment for Primary and Metastatic Liver Tumors
04/25/2024
At the 2023 CIRSE Annual Meeting, first results from the #HOPE4LIVER trial evaluating histotripsy for primary and metastatic liver tumors were reported.
At the 2023 CIRSE Annual Meeting, first results from the #HOPE4LIVER trial evaluating histotripsy for primary and metastatic liver tumors were reported.
At the 2023 CIRSE Annual...
04/25/2024
IO Learning
News
First-of-Its-Kind Surgical Foam Technology Improves Operating Room Workflow
04/24/2024

Syntervention Press Release

Syntervention Press Release
Rocky Mount, North Carolina, USA, April 24, 2024 — Syntervention, Inc., a medical device company focused on meeting critical needs in the healthcare space, announces the impact of using its SWICKER® Radiopaque Surgical Foam Sponge in open...
Rocky Mount, North Carolina, USA, April 24, 2024 — Syntervention, Inc., a medical device company focused on meeting critical needs in the healthcare space, announces the impact of using its SWICKER® Radiopaque Surgical Foam Sponge in open...
Rocky Mount, North Carolina,...
04/24/2024
EP Lab Digest
News
Fluidx Medical Reveals New Embolic Platform for Internal Bleeding, Tumor Treatment, and Other Uses
11/30/2023
Salt Lake City (UT) – Fluidx Medical today released information about their new ULTRA™ embolic platform designed to make therapeutic embolization procedures safer, better, and faster.   Embolization is a minimally invasive...
Salt Lake City (UT) – Fluidx Medical today released information about their new ULTRA™ embolic platform designed to make therapeutic embolization procedures safer, better, and faster.   Embolization is a minimally invasive...
Salt Lake City (UT) – Fluidx...
11/30/2023
Vascular Disease Management

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement